drugset / Trial / NCT04553003
Glucocorticosteroid Therapy on Drug-induced Liver Injury: a Prospective Non-randomized Concurrent Control Trial
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the safety and efficacy of glucocorticosteroid for treatment of drug-induced liver injury.
Timeline
- Start
- 2020-08-01
- Primary completion
- 2025-04-01
- Completion
- 2025-04-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methylprednisolone | Other / unclassified | 0.4 mg/kg | Oral |
| Subject | Prednisone | Other / unclassified | 0.4 mg/kg | Oral |
| Comparator | Polyene Phosphatidylcholine | Small molecule | — | Intravenous |